Charles Schwab’s Acorda Therapeutics, Inc. ACOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-129
Closed -$11K 3529
2020
Q4
$11K Hold
129
﹤0.01% 3390
2020
Q3
$9K Sell
129
-1,473
-92% -$103K ﹤0.01% 3337
2020
Q2
$142K Sell
1,602
-982
-38% -$87K ﹤0.01% 3211
2020
Q1
$290K Buy
2,584
+39
+2% +$4.38K ﹤0.01% 2905
2019
Q4
$624K Buy
2,545
+406
+19% +$99.5K ﹤0.01% 2738
2019
Q3
$737K Buy
2,139
+95
+5% +$32.7K ﹤0.01% 2656
2019
Q2
$1.88M Sell
2,044
-627
-23% -$577K ﹤0.01% 2391
2019
Q1
$4.26M Buy
2,671
+12
+0.5% +$19.1K ﹤0.01% 2045
2018
Q4
$4.97M Sell
2,659
-54
-2% -$101K ﹤0.01% 1904
2018
Q3
$6.4M Sell
2,713
-45
-2% -$106K ﹤0.01% 1910
2018
Q2
$9.5M Buy
2,758
+320
+13% +$1.1M 0.01% 1636
2018
Q1
$6.92M Sell
2,438
-86
-3% -$244K 0.01% 1755
2017
Q4
$6.5M Buy
2,524
+168
+7% +$432K 0.01% 1776
2017
Q3
$6.69M Sell
2,356
-379
-14% -$1.08M 0.01% 1721
2017
Q2
$6.47M Sell
2,735
-496
-15% -$1.17M 0.01% 1653
2017
Q1
$8.14M Buy
3,231
+23
+0.7% +$58K 0.01% 1452
2016
Q4
$7.24M Sell
3,208
-586
-15% -$1.32M 0.01% 1495
2016
Q3
$9.51M Sell
3,794
-602
-14% -$1.51M 0.01% 1206
2016
Q2
$13.5M Buy
4,396
+1,101
+33% +$3.37M 0.02% 873
2016
Q1
$10.5M Sell
3,295
-1,278
-28% -$4.06M 0.01% 1019
2015
Q4
$23.5M Buy
4,573
+143
+3% +$734K 0.03% 534
2015
Q3
$14.1M Sell
4,430
-1
-0% -$3.18K 0.02% 747
2015
Q2
$17.7M Buy
4,431
+80
+2% +$320K 0.02% 634
2015
Q1
$17.4M Buy
4,351
+1,415
+48% +$5.65M 0.02% 627
2014
Q4
$14.4M Buy
2,936
+1,834
+166% +$9M 0.02% 660
2014
Q3
$4.48M Buy
1,102
+59
+6% +$240K 0.01% 1461
2014
Q2
$4.22M Buy
1,043
+129
+14% +$522K 0.01% 1537
2014
Q1
$4.16M Buy
914
+25
+3% +$114K 0.01% 1479
2013
Q4
$3.12M Sell
889
-204
-19% -$715K 0.01% 1628
2013
Q3
$4.65M Sell
1,093
-455
-29% -$1.93M 0.01% 1242
2013
Q2
$6.45M Buy
+1,548
New +$6.45M 0.01% 836